JP2016509059A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016509059A5 JP2016509059A5 JP2015558954A JP2015558954A JP2016509059A5 JP 2016509059 A5 JP2016509059 A5 JP 2016509059A5 JP 2015558954 A JP2015558954 A JP 2015558954A JP 2015558954 A JP2015558954 A JP 2015558954A JP 2016509059 A5 JP2016509059 A5 JP 2016509059A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- glycerophosphate
- enteric coating
- core
- effective amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 claims 20
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 claims 6
- 239000002702 enteric coating Substances 0.000 claims 6
- 238000009505 enteric coating Methods 0.000 claims 6
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 claims 6
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims 4
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims 4
- 239000001736 Calcium glycerylphosphate Substances 0.000 claims 2
- UHHRFSOMMCWGSO-UHFFFAOYSA-L calcium glycerophosphate Chemical group [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 claims 2
- 229940095618 calcium glycerophosphate Drugs 0.000 claims 2
- 235000019299 calcium glycerylphosphate Nutrition 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 230000003111 delayed effect Effects 0.000 claims 2
- 208000015943 Coeliac disease Diseases 0.000 claims 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims 1
- 206010028391 Musculoskeletal Pain Diseases 0.000 claims 1
- 102000000591 Tight Junction Proteins Human genes 0.000 claims 1
- 108010002321 Tight Junction Proteins Proteins 0.000 claims 1
- 229960001680 ibuprofen Drugs 0.000 claims 1
- 210000001578 tight junction Anatomy 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361766976P | 2013-02-20 | 2013-02-20 | |
| US61/766,976 | 2013-02-20 | ||
| US201361827080P | 2013-05-24 | 2013-05-24 | |
| US61/827,080 | 2013-05-24 | ||
| US201361897672P | 2013-10-30 | 2013-10-30 | |
| US61/897,672 | 2013-10-30 | ||
| PCT/US2014/017408 WO2014130678A2 (en) | 2013-02-20 | 2014-02-20 | Methods and compositions of treating and preventing intestinal injury and diseases related to tight junction dysfunction |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016509059A JP2016509059A (ja) | 2016-03-24 |
| JP2016509059A5 true JP2016509059A5 (https=) | 2017-03-23 |
Family
ID=50240015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015558954A Abandoned JP2016509059A (ja) | 2013-02-20 | 2014-02-20 | 腸管損傷および密着結合の機能不全に関連する疾患の治療および予防のための方法および組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20150374725A1 (https=) |
| EP (1) | EP2958567A2 (https=) |
| JP (1) | JP2016509059A (https=) |
| KR (1) | KR20150141943A (https=) |
| CN (1) | CN105163740A (https=) |
| AU (1) | AU2014218903A1 (https=) |
| HK (1) | HK1219868A1 (https=) |
| MX (1) | MX2015010765A (https=) |
| WO (1) | WO2014130678A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201618783A (zh) | 2014-08-07 | 2016-06-01 | 艾森塔製藥公司 | 以布魯頓(Bruton)氏酪胺酸激酶(BTK)佔據和BTK再合成速率為基礎之治療癌症、免疫和自體免疫疾病及發炎性疾病之方法 |
| EP3345591A1 (en) * | 2017-01-06 | 2018-07-11 | Oystershell NV | Oral dosage form for enhanced solubilization of a poorly soluble active agent and method of preparation |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2993837A (en) * | 1959-07-13 | 1961-07-25 | Frosst & Co Charles E | Enteric coated tablets |
| US5665415A (en) | 1995-07-26 | 1997-09-09 | Akpharma Inc. | Composition and method for increasing the pH of acid foods |
| US20020099037A1 (en) * | 2001-01-19 | 2002-07-25 | Akpharma, Inc. | Method for alleviating syndromes and conditions of discomfort of the mammalian intestinal and genito-urinary tracts |
| US7402323B2 (en) | 2002-08-21 | 2008-07-22 | Akpharma, Inc. | Compositions and methods for treating skin conditions |
| CN1816324A (zh) * | 2003-07-04 | 2006-08-09 | 尼克麦德丹麦公司 | 口服用的含甲状旁腺激素(pth)的药物组合物 |
| AR045068A1 (es) * | 2003-07-23 | 2005-10-12 | Univ Missouri | Formulacion de liberacion inmediata de composiciones farmaceuticas |
| US20100041630A1 (en) * | 2007-02-14 | 2010-02-18 | Prelief Inc. | Methods for Treating or Preventing Inflammation Using a Glycerophosphate Salt |
| US20080220084A1 (en) * | 2007-03-09 | 2008-09-11 | Pfantastic Medical Research Institute, Llc | Combination therapy for alleviating pain-related conditions |
| US20100305071A1 (en) * | 2007-08-30 | 2010-12-02 | Prelief Inc. | Methods for improving healing of an oral lesion using a glycerophosphate salt |
| WO2009052489A2 (en) * | 2007-10-19 | 2009-04-23 | Alba Therapeutics Corporation | Novel inhibitors of mammalian tight junction opening |
-
2014
- 2014-02-20 WO PCT/US2014/017408 patent/WO2014130678A2/en not_active Ceased
- 2014-02-20 EP EP14709068.2A patent/EP2958567A2/en not_active Withdrawn
- 2014-02-20 JP JP2015558954A patent/JP2016509059A/ja not_active Abandoned
- 2014-02-20 HK HK16106374.5A patent/HK1219868A1/zh unknown
- 2014-02-20 MX MX2015010765A patent/MX2015010765A/es unknown
- 2014-02-20 KR KR1020157025637A patent/KR20150141943A/ko not_active Withdrawn
- 2014-02-20 AU AU2014218903A patent/AU2014218903A1/en not_active Abandoned
- 2014-02-20 US US14/768,373 patent/US20150374725A1/en not_active Abandoned
- 2014-02-20 CN CN201480009770.0A patent/CN105163740A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019526543A5 (https=) | ||
| RU2018145985A (ru) | Антагонисты активина-actrii и их применение для лечения нарушений костной ткани и других нарушений | |
| AR128816A2 (es) | Formas de dosificación farmacéutica de perlas de cisteamina | |
| EP2827856A4 (en) | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MUSCLE DISEASES | |
| JP2014530840A5 (https=) | ||
| PT3405215T (pt) | Métodos para o tratamento da doença de danon e outros transtornos da autofagia | |
| MX2018006247A (es) | Metodos para tratar la enfermedad de alzheimer y trastornos relacionados. | |
| EP2956149A4 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HELICOBACTER PYLORI | |
| EP2978446A4 (en) | METHOD AND MEANS FOR THE TREATMENT OF MORBUS ALZHEIMER | |
| JP2016519107A5 (https=) | ||
| JP2015535291A5 (https=) | ||
| IL255314A0 (en) | Anti-ap2 antibodies and antigen-binding agents for the treatment of metabolic disorders | |
| WO2014107730A3 (en) | Use of fatty acid niacin conjugates for treating diseases | |
| IL280083A (en) | A pharmaceutical dosage form that can be administered orally and with a modified release | |
| EP3316874A4 (en) | TOPICAL AND INJECTABLE RESIQUIMOD COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC GUM DISEASES | |
| MA43758A (fr) | Procédés pour déterminer le dosage d'un agent thérapeutique et traitements associés | |
| MX2020003031A (es) | Metodo para preparar una forma de dosificacion solida que comprende anticuerpos por granulacion humeda, extrusion y esferonizacion. | |
| EP3373922A4 (en) | COMPOSITIONS AND METHODS FOR TREATING HOMOCYSTINURIA | |
| JP2016509059A5 (https=) | ||
| HUE042932T2 (hu) | Koleszterinészter-transzferprotein (CETP) inhibitor és az említett inhibitort tartalmazó gyógyászati készítmény szív- és érrendszeri betegségek kezelésében vagy megelõzésében való alkalmazásra | |
| EP2877095A4 (en) | IMAGING METHOD AND THERAPEUTIC METHOD FOR THE TREATMENT OF SUB-DAY TREATMENT DUMORS | |
| JP2015516452A5 (https=) | ||
| EP3302529A4 (en) | COMPOSITIONS AND METHODS FOR TREATING GALLENA GANGATRESIA IN NEWBORNS | |
| DK3666262T3 (da) | Farmaceutiske orale doseringsformer til behandling af stofskifteforstyrrelser og lignende sygdomme ved orkestreret frigivelse af enterokiner | |
| JP2015516450A5 (https=) |